Unknown

Dataset Information

0

Targetability of STAT3-JAK2 fusions: implications for T-cell lymphoproliferative disorders of the gastrointestinal tract.

ABSTRACT:

SUBMITTER: Hu G 

PROVIDER: S-EPMC7196010 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Recurrent <i>STAT3-JAK2</i> fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract.
| S-EPMC5958657 | biostudies-literature
Unknown Indolent T-cell lymphoproliferative disease of the gastrointestinal tract.
| S-EPMC3837508 | biostudies-literature
Unknown Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders.
| S-EPMC9139583 | biostudies-literature
Unknown Clinicopathologic features and molecular profiling of indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract.
| S-EPMC12274642 | biostudies-literature
Unknown EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 2).
| S-EPMC8469260 | biostudies-literature
Unknown Clinical and genetic profile of Chinese patients with indolent natural killer-cell lymphoproliferative disorder of the gastrointestinal tract.
| S-EPMC11415802 | biostudies-literature
Unknown STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.
| S-EPMC3471515 | biostudies-literature
Unknown Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling.
| S-EPMC5722580 | biostudies-literature
Unknown Clinical and therapeutic implications of BRAF fusions in histiocytic disorders.
| S-EPMC9240055 | biostudies-literature
Unknown STAT3 and STAT5B Mutations in T/NK-Cell Chronic Lymphoproliferative Disorders of Large Granular Lymphocytes (LGL): Association with Disease Features.
| S-EPMC7760806 | biostudies-literature